Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 AUD | +4.17% | -4.76% | -9.09% |
05-09 | Transcript : PYC Therapeutics Limited, Q2 2024 Earnings Call, May 09, 2024 | |
04-22 | Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 308M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Secures US FDA Clearance to Start Retinitis Pigmentosa Trial